the efficacy of local adoptive immunotherapy with human lymphokine-activated killer cells and recombinant interleukin 2 ( ril-2 ) in growth inhibition of established squamous cell carcinoma of the head and neck ( scchn ) was evaluated in a nude mouse model .
C0086418
human
C0021756
recombinant interleukin 2